...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Still not finding on ClinicalTrials gov

jb... Is this not it? 

Apr 16, 2021 - ) An Open-Label Study to Assess the Safety and Effect on Clinical Course and Key Biomarkers of Oral Apabetalone in Hospitalized Subjects with COVID-19 Infection in Addition to Standard of Care (SOC) RVX000222 (Apabetalone) Resverlogix Corp 2021-04-06 N/A CORE-COVID (Control # 249936) A Randomized Clinical Trial Comparing 7 Days Treatment with Corticosteroids"

 

Koo

Share
New Message
Please login to post a reply